New England Journal of Medicine News
Most Popular New England Journal of Medicine Story
Drug outfits doing better at posting trial data
According to an editorial in the New England Journal of Medicine, the number of trials posted at the NIH's site with incomplete data has dropped from 26 percent before 2006 to 8 percent in the first 11 months of last year. The increase in voluntary disclosure came after some blistering criticism that large pharma companies had been essentially hiding data that raised safety issues regarding its drugs. The better response, though, is unlikely to dull the appetite in Congress for …
... Read more...Latest Headlines
- March 28, 2008
- January 29, 2008
- January 18, 2008
- January 17, 2008
- September 12, 2007
- August 14, 2007
- January 10, 2007
- December 20, 2006
- November 15, 2006
- March 29, 2006
- March 22, 2006
- March 1, 2006
- February 22, 2006
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
